Conolidine’s analgesic effects stem from its conversation with non-opioid pain pathways. In contrast to opioids, which bind to µ-opioid receptors while in the central anxious technique, conolidine modulates alternate molecular targets. A Science Innovations review observed that conolidine interacts While using the atypical chemokine receptor ACKR3/CXCR7, which regulates opioid https://roberti755hwl3.smblogsites.com/profile